Bioneer KRX:064550KOSDAQ

바이오니아 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days2
DART filings, 7 days0
Articles tracked2since Sep 11

In Q2 2026, Bioneer reported revenue of ₩96.2bn, up 8.9% year on year, and operating profit of ₩1.2bn. Bioneer (바이오니아) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 12 with 1 article. It was most often mentioned alongside Boryung.

Bioneer quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩96.2bn+8.9%₩1.2bn−₩1.1bn
Q1 2026₩81.8bn+10.7%−₩526m−₩2.8bn
Q4 2025 derived₩79.9bn+13.4%₩2.7bn₩166m
Q3 2025₩88.1bn+33.7%₩2.9bn₩63m
Q2 2025₩88.3bn+12.5%₩5.3bn₩345m
Q1 2025₩73.9bn-6.7%₩4.3bn₩1.1bn
Q4 2024 derived₩70.4bn+9.9%−₩7.4bn−₩8.2bn
Q3 2024₩65.9bn-10.7%−₩8.2bn−₩9.6bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Bioneer top stories 2 weeks, by number of outlets

  1. 1
    "세계 시장 잡았다"… 바이오니아, 분자진단·탈모 치료제 글로벌 직행
    1 outlets · 1 articlesFirst report Sep 13 13:49 핀포인트뉴스
  2. 2
    AI 재확산 우려에 백신·진단시약주 들썩… 바이오니아·보령 '방긋'
    1 outlets · 1 articlesFirst report Sep 12 09:38 핀포인트뉴스Boryung

Latest Bioneer news Korean headlines